Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction
(2023). Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction. EKB Journal Management System, 3(2), -. doi: 10.21608/esdlj.2023.456190
. "Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction". EKB Journal Management System, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456190
(2023). 'Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction', EKB Journal Management System, 3(2), pp. -. doi: 10.21608/esdlj.2023.456190
Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction. EKB Journal Management System, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456190

Investigating CD14 and CD16 in diabetics with nonalcoholic fatty liver disease associated with gonadal dysfunction

Egyptian Society of Diabetes and Lipidology Journal
Volume 3, Issue 2, October 2023    PDF (756.39 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2023.456190
Abstract
Non-alcoholic fatty liver disease (NAFLD) is one of the components of metabolic syndrome associated with type 2 diabetes mellitus, dyslipidemia and central obesity 20 which led to acquired hypogonadism and create a state of meta-inflammation. 
Statistics
Article View: 36
PDF Download: 7